THORELL MARELLA (Chief Financial Officer) sold 18.1% of their position (2K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $19.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/9/2023ACC: 0001694665-23-000133
Officer· Chief Financial Officer
Since Jul 2022
-2K
Net shares
Net seller
$19.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 8.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
—
Trade value
—
% of position
142.1%
8/7/2023
4.57K→11.07K
Common Stock
Direct
Shares
−2K
Price / share
$9.51
Trade value
$19.06K
% of position
18.1%
8/8/2023
11.07K→9.07K
Total
Net shares
+4.50K
Net value
-$19.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2023 | M · Option Exercise | +6.50K | — | — | 142.1% | 4.57K | 11.07K |
| Common Stock Direct | 8/8/2023 | S · Sale | −2K | $9.51 | $19.06K | 18.1% | 11.07K | 9.07K |
| Total | +4.50K | -$19.06K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
Held after
13K
Exercisable
—
8/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.50K shares | 8/7/2023 | M · Option Exercise | −6.50K | — | 13K |